TSC1 and neoplasm: Furthermore, the case was negative for TSC mutation subsequent to conventional treatment for disease progression, which may be attributable to tumor heterogeneity or the sensitivity of the genetic testing technology on the one hand, and the genetic alteration of the tumor after treatment on the other hand.